ctDNA predicts early treatment response in HPV-associated anal cancer
Dr Tobias Maurer speaks to ecancer at EMUC 2019 in Vienna about oligometastatic disease in urological cancers.
He explains the importance of imaging, and some of the current guidelines on surgical techniques.
Dr Maurer recalls some of the highlights from the session at EMUC, referencing important studies and literature.
ctDNA predicts early treatment response in HPV-associated anal cancer
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Cancer mutation prediction using artificial intelligence
Best practice in HRRm testing in patients with metastatic prostate cancer
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients